4 Quotes by David Risinger

Seniors appear to be filling incremental prescriptions, given additional drug coverage.

It is possible that pharmaceutical group stock momentum could carry (Lilly) higher, but we believe the risk/reward warrants a neutral rating.

We anticipate a relief rally for pharmaceutical stocks.

Instead, it was driven by the core business and a lower tax rate.